LIGAND PHARMACEUTICALS INCORPORATED Accrued Liabilities, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Accrued Liabilities, Current of $31.87 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $31.87M.
- 2026-03-31: Accrued Liabilities, Current $31.84M.
- 2025-12-31: Accrued Liabilities, Current $31.45M.
- 2025-09-30: Accrued Liabilities, Current $24.08M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $31.87M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $31.84M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $31.45M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $24.08M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $17.46M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $23.54M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $27.91M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $15.60M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $12.17M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $12.43M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $12.47M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $10.63M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $7.29M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $14.98M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $15.68M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $19.34M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $14.55M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $15.88M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $17.58M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $12.24M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $10.11M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $12.11M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $18.53M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $14.50M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $12.83M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $11.85M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $8.58M 10-K · filed 2021-02-24 | $9.84M 10-K · filed 2020-02-27 |
| 2019-09-30 | $13.06M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $11.54M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $14.77M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $19.20M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $9.27M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $9.31M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $8.48M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $7.38M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $6.42M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.33M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $4.68M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $6.40M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $6.67M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $4.95M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $3.67M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $5.41M 10-K · filed 2017-02-28 | $5.40M 10-K · filed 2016-02-26 |
| 2015-09-30 | $4.16M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.63M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $4.26M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.87M 10-K · filed 2016-11-14 | $5.34M 10-K · filed 2014-12-01 |
| 2014-09-30 | $4.31M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $3.24M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $5.45M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $5.34M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $4.62M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $4.02M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $4.52M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $4.96M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $5.38M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.23M 10-Q/A · filed 2012-11-14 | |
| 2012-03-31 | $4.14M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $5.05M 10-K · filed 2013-03-14 | $8.26M 10-K · filed 2012-02-23 |
| 2011-09-30 | $7.48M 10-Q/A · filed 2012-02-10 | |
| 2011-06-30 | $6.81M 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $8.86M 10-K/A · filed 2012-11-14 |